Pioglitazone, bladder cancer, and detection bias

被引：6

作者：

Dolin, Paul ^{[1
]}

机构：

[1] Takeda Dev Ctr Europe, London WC2B 4AE, England

来源：

JOURNAL OF DIABETES | 2014年 / 6卷 / 02期

关键词：

D O I：

10.1111/1753-0407.12087

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：193 / 194

页数：2

共 5 条

[1]

Capen C.C., 1999, IARC Scientific Publication., V147

[2]

Detection Bias and Overestimation of Bladder Cancer Risk in Type 2 Diabetes A matched cohort study [J].

Colmers, Isabelle N. ;

Majumdar, Sumit R. ;

Yasui, Yutaka ;

Bowker, Samantha L. ;

Marra, Carlo A. ;

Johnson, Jeffrey A. .

DIABETES CARE, 2013, 36 (10) :3070-3075

[3]

Carcinogenicity of some drugs and herbal products [J].

Grosse, Yann ;

Loomis, Dana ;

Lauby-Secretan, Beatrice ;

El Ghissassi, Fatiha ;

Bouvard, Veronique ;

Benbrahim-Tallaa, Lamia ;

Guha, Neela ;

Baan, Robert ;

Mattock, Heidi ;

Straif, Kurt .

LANCET ONCOLOGY, 2013, 14 (09) :807-808

[4]

Lewis D, 2012, COHORT STUDY PIOGLIT

[5]

Diabetes and cancer relationships [J].

Wang, Tiange ;

Ning, Guang ;

Bloomgarden, Zachary .

JOURNAL OF DIABETES, 2013, 5 (04) :378-390

← 1 →